Additional information
Pale yellow Powder
2518153-95-0
ACI-020813
75.0-76.2°C
C11H12BrN3
266.14
Ambient
2-8°C
ocular hypertension
Pharmaceutical Impurity Standards
N-propylamino-5-bromoquinoxaline
6-(2-imidazoline-2-ylidineamino)-1,2,3,4-tetrahydroquinoxalin-2,3-dione
2-Quinoxalinamine, 5-bromo-N-propyl